Bianalisi Secures €470 Million Financing Package for Expansion
Deal News | Feb 28, 2025 | The Carlyle Group
Carlyle's Global Credit platform and Arcmont Asset Management have arranged a €470 million financing package for Bianalisi, an Italian healthcare diagnostics company. Bianalisi will use the funds to invest in market consolidation and refinance existing debt, supporting its growth strategy across Italy's fragmented healthcare diagnostics sector. The firm has achieved significant growth through both organic means and over 60 acquisitions since receiving investment from Charme Capital Partners. Carlyle and Arcmont's investment aligns with their strategy to provide flexible capital solutions in the European health sector. Bianalisi, led by CEO Giovanni Gianolli, operates a widespread network of diagnostic services and serves over 15,000 patients daily in Italy. The financing package underscores the confidence of global investors in the continued expansion and domain expertise of Bianalisi.
Sectors
- Healthcare
- Investment Management
- Private Debt
Geography
- Italy – Bianalisi operates across 13 regions in Italy and the financial deal is focused on the Italian market.
- Europe – Arcmont operates across Europe, making them a significant player in providing finance in this geography.
- Global – Carlyle, as a global investment firm, indicates the international nature of the financing deal.
Industry
- Healthcare – The article deals with Bianalisi, a company that provides healthcare diagnostics services across Italy.
- Investment Management – Carlyle and Arcmont, two investment entities, are heavily involved in this financing deal illustrating activities in investment management.
- Private Debt – Arcmont Asset Management's focus on providing private debt solutions is crucial to the financing of Bianalisi.
Financials
- €470 million – The total financing package provided to Bianalisi for market expansion and debt refinancing.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Bianalisi | Target Company | Companies | A leading independent diagnostics platform in Italy that aims to consolidate its market presence. |
| Carlyle Group | Financing Partner | Companies | A global investment firm providing a significant part of the €470 million financing to Bianalisi. |
| Arcmont Asset Management | Financing Partner | Companies | A European private credit asset management firm participating in the financing package for Bianalisi. |
| Natixis | Financing Partner | Companies | Involved in arranging the financing package alongside Carlyle and Arcmont. |
| Charme Capital Partners | Investor | Companies | An Italian private equity firm that has previously invested in Bianalisi, supporting its growth through acquisitions. |